Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Alanine aminotransferase increased
ADR ID BADD_A00134
ADR Hierarchy
13      Investigations
13.03      Hepatobiliary investigations
13.03.04      Hepatobiliary function diagnostic procedures
13.03.04.005      Alanine aminotransferase increased
Description A finding based on laboratory test results that indicate an increase in the level of alanine aminotransferase (ALT or SGPT) in the blood specimen. [CTCAE]
MedDRA Code 10001551
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Alanine aminotransferase increase | Alanine aminotransferase increased | ALT increased | Glutamic-pyruvate transaminase increased | Glutamic-pyruvic transam incr | Glutamic-pyruvic transaminase increased | GPT inc | GPT increased | GPT increased transient | Serum glutamic-pyruvic ta incr | Serum glutamic-pyruvic transaminase increased | SGPT increased | Transaminase glutamic-pyruvic increased | Serum glutamic-pyruvic ta increased | ALT flare up | ALT high
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01170Interferon beta-1b--
BADD_D01171Interferon gamma-1b--
BADD_D01195Irinotecan--
BADD_D01197Iron--
BADD_D01201Isavuconazonium sulfate--
BADD_D01204Isoniazid--
BADD_D01211Isosorbide mononitrate--
BADD_D01217Itraconazole--
BADD_D01242Lamivudine--
BADD_D01243Lamotrigine--
BADD_D01245Lansoprazole--
BADD_D01248Lapatinib--
BADD_D01250Lasofoxifene--
BADD_D01252Leflunomide--
BADD_D01253Lenalidomide--
BADD_D01254Lenvatinib--
BADD_D01255Lercanidipine--
BADD_D01295Linezolid--
BADD_D01298Liraglutide--
BADD_D01310Lomefloxacin hydrochloride--
BADD_D01311Lomitapide--
BADD_D01312Lomitapide mesylate--
BADD_D01316Loracarbef--
BADD_D01328Lubiprostone--
BADD_D01330Lurasidone--
BADD_D01352Maraviroc--
BADD_D01353Mebendazole--
BADD_D01366Medroxyprogesterone acetate--
BADD_D01374Meloxicam--
BADD_D01375Meloxicam sodium--
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 16 Pages